Hao Wang | Clinical Trials and Statistical Designs | Research Excellence Award

Dr. Hao Wang | Clinical Trials and Statistical Designs | Research Excellence Award

Sichuan Provincial People’s Hospital, University of Electronic Science and Technology of China | China

Hao Wang is an accomplished physician scientist in the field of imaging and nuclear medicine, with advanced training focused on molecular imaging and targeted radionuclide therapy. His academic background emphasizes the development and clinical translation of novel molecular probes for precise disease diagnosis and therapy monitoring. His research integrates imaging physics, radiopharmaceutical science, and clinical nuclear medicine to improve diagnostic accuracy and therapeutic outcomes, particularly in precision medicine. He has led and contributed to multiple competitively funded research initiatives at national, provincial, and institutional levels, reflecting sustained recognition of his scientific leadership. His projects span applied clinical research, basic and translational investigations, and medical education reform, demonstrating a multidisciplinary approach to innovation in healthcare. Through these studies, he has advanced methodologies for imaging-based disease characterization, optimized radionuclide-targeted treatment strategies, and supported the integration of novel probes into clinical practice. His work also contributes to capacity building in medical imaging through education-focused research initiatives. Collectively, his research efforts highlight a strong commitment to advancing nuclear medicine technologies, bridging laboratory discoveries with patient-centered applications, and promoting evidence-based clinical innovation within modern imaging sciences.

Citation Metrics (Scopus)

400
300
200
100
0

Citations
134

Documents
57

h-index
6

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Aasma Shaukat | Clinical Trials and Statistical Designs | Best Researcher Award

Dr. Aasma Shaukat | Clinical Trials and Statistical Designs | Best Researcher Award

New York University | United States

Dr. Aasma Shaukat, M.D., M.P.H., is an internationally acclaimed gastroenterologist, epidemiologist, and academic leader recognized for her transformative contributions to colorectal cancer prevention, gastrointestinal outcomes research, and population health. She serves as Director of Gastrointestinal Outcomes Research, Robert M. and Mary H. Glickman Endowed Professor of Medicine, Professor of Population Health, Co-Director of the Translational Research Education and Career (TREC) Program, and Program Director for the KL2 Scholars Program at the Clinical and Translational Science Institute at NYU Grossman School of Medicine, while also serving as a staff physician at the VA New York Harbor Healthcare System. Before joining NYU, she led the Gastroenterology Section at the Minneapolis VA Health Care System and was a core investigator at the Center for Chronic Disease Outcomes Research, establishing herself as a national authority in outcomes-based gastroenterology. Dr. Shaukat holds an M.B., B.S. from The Aga Khan University Medical College in Karachi and an M.P.H. in International Health and Epidemiology from Johns Hopkins Bloomberg School of Public Health, followed by residency training in Internal Medicine at the State University of New York and fellowship training in Gastroenterology at Emory University School of Medicine. Board-certified in Internal Medicine and Gastroenterology, she has combined clinical expertise with advanced epidemiologic research to drive evidence-based improvements in digestive health and preventive care. Her research has shaped international colorectal cancer screening practices through landmark studies demonstrating the long-term mortality benefit of fecal occult blood testing, influencing screening guidelines worldwide. With more than 273 peer-reviewed publications and numerous invited lectures, Dr. Shaukat has become one of the most cited researchers in gastroenterology, with an h-index of 50, i10-index of 155, and over 9,245 citations according to Scopus, underscoring her scientific impact. Her work encompasses endoscopic quality improvement, health disparities, cost-effectiveness of screening programs, and novel noninvasive diagnostics for gastrointestinal diseases. In addition to her research, Dr. Shaukat is a dedicated mentor and educator who has guided countless trainees and junior faculty, championing diversity and inclusion in academic medicine. She serves on the Board of Trustees for the American College of Gastroenterology, chairs the Clinical Practice Section of the American Gastroenterological Association Institute, and contributes to several national advisory and planning committees, including ASCO GI, GIQUIC, PCORI, and the VA GI Field Advisory Board. A recipient of numerous prestigious honors such as the ASGE Endoscopic Research Mentoring Award, ACG MVP SCOPY Award for Colon Cancer Prevention, and NYU Research Mentor of the Year Award, she continues to shape the future of gastroenterology through innovation, mentorship, and leadership. Dr. Shaukat’s enduring legacy lies in her ability to merge clinical excellence, epidemiologic insight, and translational impact to advance gastrointestinal health globally and inspire the next generation of physician-scientists committed to research-driven healthcare transformation.

Profiles: Scopus Google Scholar | Orcid

Featured Publications

Udaikumar, J., Nimmagadda, Shaukat, A.,R., Ingawale, S., Lella, V. V., Vijayakumar, K., et al. (2025). Current perspectives on colorectal cancer screening and surveillance in the geriatric population. Current Gastroenterology Reports, 27(1), 34.

Singal, A. G., Quirk, L., Boike, J., Chernyak, V., Feng, Z., Giamarqo, G., Kanwal, F., … (2025). Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel. Hepatology, 82(3), 794–809.

Shaukat, A., Hu, J., Zhao, Y., Faulx, G., Augustin, A., Murphy, S., Stevens, E., et al. (2025). A randomized clinical trial of multi-level intervention to improve colorectal cancer screening rates at multiple federally qualified health care centers in New York City. Contemporary Clinical Trials, 108115.

Farooque, U., Murtaza, M., Umer, M., Johar, A., Aparna, F., Khan, A. R., Kumar, A., et al. (2025). Advancing health equity through telehealth: A systematic review and meta-analysis of remote vs. in-person weight-loss interventions among Black women with obesity. Current Obesity Reports, 14(1), 72.

Tang, C. Z., Delau, O. R., Katz, S., Axelrad, J. E., Hudesman, D., Shaukat, A., et al. (2025). Mild endoscopic disease activity is associated with adverse outcomes among older adults with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics.